|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Mar―08 |
Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 |
Tamara Hamlish, Elizabeth L Papautsky |
2 |
[GO] |
2022―Mar―08 |
Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer |
Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12) Claudio Ferranti, Secondo Folli, Massimiliano Gennaro, Filippo G de Braud, Claudio Vernieri, Maria Carmen De Santis, Laura Lozza, Andrea Vingiani, Giancarlo Pruneri, Giovanni Apolone, Alfonso Marchianò, Gianfranco P Scaperrotta |
3 |
[GO] |
2022―Mar―08 |
Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered |
Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons |
4 |
[GO] |
2022―Mar―08 |
Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery |
Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson |
5 |
[GO] |
2022―Mar―08 |
Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak |
Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4) Laure Pierard, Jean-Marc Limacher, Michel Velten, Thierry Petit |
6 |
[GO] |
2022―Mar―08 |
Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4) Luc JA Strobbe, Jelle Wesseling, Ruud M Pijnappel, Mireille JM Broeders |
7 |
[GO] |
2022―Mar―08 |
Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients |
Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12) Ester JM Siemerink, Luc JA Strobbe, Marie-Jeanne TFD Vrancken Peeters, Linetta B Koppert, Marc AM Mureau, Agnes Jager, Mireille JM Broeders, Marc BI Lobbes, Helena M Verkooijen, Jelle Wesseling, Marjolein Smidt, Vivianne CG Tjan-Heijnen |
8 |
[GO] |
2022―Mar―08 |
Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic |
Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi |
9 |
[GO] |
2022―Mar―08 |
Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2) Melissa L Bondy, Allison W Kurian |
10 |
[GO] |
2022―Mar―08 |
Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic |
Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2) Steve Power, Grace Campbell |
11 |
[GO] |
2022―Mar―08 |
Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic |
Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2) Melissa L Bondy, Allison W Kurian |
12 |
[GO] |
2022―Mar―08 |
Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic |
Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6) Alexander Prokhorov, Bernardo Rapoport, Vladimir Semiglazov, Ling-Ming Tseng, Eduardo Yanez Ruiz, Sibylle Loibl |
13 |
[GO] |
2022―Mar―08 |
Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic |
Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2) Abram Recht, Daphna Y Spiegel |
14 |
[GO] |
2022―Mar―08 |
Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment |
Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5) Ellen Perkins, Timothy Panella, Lisa Duncan, Stuart VanMeter, John Bell |
15 |
[GO] |
2022―Mar―08 |
Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences |
Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk |
16 |
[GO] |
2022―Mar―08 |
Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications |
Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3) Carla Falkson, David Hicks, Bradley Turner |
17 |
[GO] |
2022―Mar―08 |
Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination |
Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8) Ashita Mummareddy, Ahmed M Ashai, Annamaria Wilhelm, Robert Maxwell, Martha Wasserman, Neema Patel, Andrey Morozov, Saranya Chumsri |
18 |
[GO] |
2022―Mar―08 |
Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy |
Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5) Atsushi Yoshida, Junko Takei, Naoki Hayashi, Daiki Kobayashi, Hideko Yamauchi |
19 |
[GO] |
2022―Mar―08 |
Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination |
Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2) Cynthia Evans, Sukeshi Arora |
20 |
[GO] |
2022―Mar―08 |
Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience |
Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4) Abhinav Rohatgi, Shubhada Dhage, Amber Guth, Nina D'Abreo |
21 |
[GO] |
2022―Mar―08 |
Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center |
Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro |
22 |
[GO] |
2022―Mar―08 |
Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives |
Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4) Jordan Baum, Shubhada Dhage, Amber Guth, Nina D'Abreo |
23 |
[GO] |
2022―Mar―08 |
Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients |
Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3) Alvaro Moreno-Aspitia, Christopher P Marquez, Keith L. Knutson |
24 |
[GO] |
2022―Mar―08 |
Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer |
Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19) Anthony Rooney, Stephen Williamson, Gary Doolittle, Weijing Sun, Bruce F Kimler, Anne P O'Dea, Lauren E Nye, Joseph P McGuirk, Ziyan Pessetto, Lisa Haney, Nicole Balmaceda, Laura Mitchell, Karissa Finke, Maggie Nelson, Dinesh Pal Mudaranthakam, Natalie Streeter, Stephanie Lafaver, Jaimie Heldstab, Qamar J Khan |
25 |
[GO] |
2022―Mar―08 |
Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors |
Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11) Caroline Barabell, Jennifer A. Hutchinson, Seth A. Wander, Aron S. Rosenstock, Leif W. Ellisen, Beverly Moy, Steven J. Isakoff, Justin F. Gainor, A. John Iafrate, Aditya Bardia, Laura M. Spring |
26 |
[GO] |
2022―Mar―08 |
Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) |
Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7) Mario Giovanni Chilelli, Antonella Virtuoso, Carlo Signorelli, Julio R Giron Berrios, Marta Schirripa, Rossella Donghia, Enzo Maria Ruggeri |
27 |
[GO] |
2022―Mar―08 |
Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction |
Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6) Susan Dent, Sarah Sammons, Jeremy Force, Kelly Westbrook, Carey Anders, Rebecca Shelby |
28 |
[GO] |
2022―Mar―08 |
Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study |
Chandralekha Krishnan |
29 |
[GO] |
2022―Mar―08 |
Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 |
Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli |
30 |
[GO] |
2022―Mar―08 |
Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain |
Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari |
31 |
[GO] |
2021―Nov―10 |
Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients |
Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27) Nathalie Nguyen, Laurel J Finster, Joslyn Foley, Justin Darrah, Jun Gong, Ronald Paquette, Alain C Mita, Robert Vescio, Inderjit Mehmi, Reva Basho, Warren G Tourtellotte, Carissa A Huynh, Gil Y Melmed, Jonathan Braun, Dermot PB McGovern, Emebet Mengesha, Greg Botwin, John C Prostko, Edwin C Frias, James L Stewart, Sandy Joung, Jennifer Van Eyk, Joseph E Ebinger, Susan Cheng, Kimia Sobhani, Karen L Reckamp, Akil Merchant |
32 |
[GO] |
2021―Jul―01 |
Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 |
Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6) Vikram Dhawan, Marc Rosenblum, Christine A. Iacobuzio-Donahue, Edward K. Avila, Bianca Santomasso, Adrienne Boire |
33 |
[GO] |
2021―Jul―01 |
Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 |
Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9) Ayelen Toro, Florencia Cascardo, Santiago Olszevicki, Nicolas Anselmino, Estefania Labanca, Emiliano Ortiz, Elba Vazquez, Javier Cotignola, Geraldine Gueron |
34 |
[GO] |
2021―Jul―01 |
Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 |
Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3) Anat Eldar-Boock, Helena F. Florindo, Ronit Satchi-Fainaro |
35 |
[GO] |
2021―Jul―01 |
Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 |
Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki |
36 |
[GO] |
2021―Jul―01 |
Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 |
Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan |
37 |
[GO] |
2021―Jul―01 |
Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 |
Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2) Paola Parrella, Massimiliano Mazza |
38 |
[GO] |
2021―Jul―01 |
Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis |
Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig |
39 |
[GO] |
2021―Jul―01 |
Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae |
Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6) Brooke Su-Velez, Julian Handler, Adin Handler, Judith Okoro, Sebhat Afework, Jay Vadgama |
40 |
[GO] |
2021―Jul―01 |
Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK |
Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4) Sophie Papa, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck |
41 |
[GO] |
2021―Jul―01 |
Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro |
Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2) Venkateshwar Madka, Chinthalapally V. Rao |
42 |
[GO] |
2021―Jul―01 |
Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) |
Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17) Alan Lew, Cristina Goman, Zachary Sagawa, Monica Thakar, Victoria Lacasse, Cherie Daly, Shuyang He, Lin Kang, Sharmila Koppisetti, Tanel Mahlakõiv, Sunday Osokoya, William van der Touw, Junhong Zhu, Greg Berk, Xiaokui Zhang, Andrew Pecora, Robert Hariri |
43 |
[GO] |
2021―Jul―01 |
Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic |
Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3) Nanao Terada, Miki Abo, Kazuo Kasahara |
44 |
[GO] |
2021―Jul―01 |
Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic |
Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom |
45 |
[GO] |
2021―Jul―01 |
Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers |
Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6) Cassandra Osei, Juan Rivera, J Trossman, Christine Weldon, Elizabeth Adetoro, Melissa Simon |
46 |
[GO] |
2021―Jul―01 |
Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) |
Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain |
47 |
[GO] |
2021―Jul―01 |
Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study |
Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5) Juan Haro-Varas, Shirley Quintana-Truyenque, Luis Malpica, Henry Gomez-Leonidas, Tatiana Vidaurre-Rojas |
48 |
[GO] |
2021―Jul―01 |
Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs |
Said A. Goueli, Kevin Hsiao |
49 |
[GO] |
2021―Jul―01 |
Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model |
Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik |
50 |
[GO] |
2021―Jul―01 |
Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study |
Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi |
51 |
[GO] |
2021―Jul―01 |
Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method |
Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle |
52 |
[GO] |
2021―Jul―01 |
Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs |
Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra |
53 |
[GO] |
2021―Jul―01 |
Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel |
Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu |
54 |
[GO] |
2021―Jul―01 |
Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score |
Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44) Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C. Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Josep Tabernero, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Andrea Marrari, M. Carmen Carmona-García, Neha Chopra, Carlo Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué, Alvin J. Lee, Thomas Newsom-Davis, Andrea Patriarca, Lorenza Rimassa, Armando Santoro, Alessandra Gennari, Nikolaos Diamantis, David J. Pinato |
55 |
[GO] |
2021―Jul―01 |
Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response |
Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell |
56 |
[GO] |
2021―Jul―01 |
Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases |
Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3) Bumseok Kim, Soon B. Hwang, HoonSung Jeh |
57 |
[GO] |
2021―Jul―01 |
Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus |
Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post |
58 |
[GO] |
2021―Jul―01 |
Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma |
Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25) Elena Bokatenkova, Beatriz Sanchez-Espiridion, Carmen Behrens, Luisa M. Solis, Boning Gao, Luc Girard, Jianjun Zhang, Boris Sepesi, Tina Cascone, Lauren A. Byers, Don L. Gibbons, Jichao Chen, Seyed Javad Moghaddam, Edwin J. Ostrin, Paul Scheet, Junya Fujimoto, Jerry Shay, John V. Heymach, John D. Minna, Steven Dubinett, Ignacio I. Wistuba, Christopher S. Stevenson, Avrum E. Spira, Linghua Wang, Humam Kadara |
59 |
[GO] |
2020―Dec―22 |
Is COVID-19 - induced platelet activation a cause of concern for cancer patients? |
Lenard M. Lichtenberger, K. Vinod Vijayan |
|